These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17457926)

  • 61. Attenuation and immunogenicity of host-range extended modified vaccinia virus Ankara recombinants.
    Melamed S; Wyatt LS; Kastenmayer RJ; Moss B
    Vaccine; 2013 Sep; 31(41):4569-77. PubMed ID: 23928462
    [TBL] [Abstract][Full Text] [Related]  

  • 62. L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines.
    Pacchioni SM; Bissa M; Zanotto C; Morghen Cde G; Illiano E; Radaelli A
    J Transl Med; 2013 Apr; 11():95. PubMed ID: 23578094
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.
    Kreijtz JH; Suezer Y; de Mutsert G; van den Brand JM; van Amerongen G; Schnierle BS; Kuiken T; Fouchier RA; Löwer J; Osterhaus AD; Sutter G; Rimmelzwaan GF
    J Infect Dis; 2009 Feb; 199(3):405-13. PubMed ID: 19061423
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection.
    Di Lullo G; Soprana E; Panigada M; Palini A; Erfle V; Staib C; Sutter G; Siccardi AG
    J Virol Methods; 2009 Mar; 156(1-2):37-43. PubMed ID: 19038289
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions.
    Katz E; Wolffe EJ; Moss B
    J Virol; 1997 Apr; 71(4):3178-87. PubMed ID: 9060681
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Extracellular vesicles containing virus-encoded membrane proteins are a byproduct of infection with modified vaccinia virus Ankara.
    Spehner D; Drillien R
    Virus Res; 2008 Oct; 137(1):129-36. PubMed ID: 18662728
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Viral glycoprotein-mediated cell fusion assays using vaccinia virus vectors.
    Bossart KN; Broder CC
    Methods Mol Biol; 2004; 269():309-32. PubMed ID: 15114023
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Third-generation smallpox vaccine strain-based recombinant vaccines for viral hemorrhagic fevers.
    Yoshikawa T
    Vaccine; 2021 Oct; 39(41):6174-6181. PubMed ID: 34521550
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain.
    Herrera E; Lorenzo MM; Blasco R; Isaacs SN
    J Virol; 1998 Jan; 72(1):294-302. PubMed ID: 9420227
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination.
    Wolffe EJ; Isaacs SN; Moss B
    J Virol; 1993 Aug; 67(8):4732-41. PubMed ID: 8331727
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effects of targeting the vaccinia virus B5R protein to the endoplasmic reticulum on virus morphogenesis and dissemination.
    Mathew EC; Sanderson CM; Hollinshead R; Hollinshead M; Grimley R; Smith GL
    Virology; 1999 Dec; 265(1):131-46. PubMed ID: 10603324
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
    Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
    Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Host range, growth property, and virulence of the smallpox vaccine: vaccinia virus Tian Tan strain.
    Fang Q; Yang L; Zhu W; Liu L; Wang H; Yu W; Xiao G; Tien P; Zhang L; Chen Z
    Virology; 2005 May; 335(2):242-51. PubMed ID: 15840523
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Different contribution of co-stimulatory molecules B7.1 and B7.2 to the immune response to recombinant modified vaccinia virus ankara vaccine expressing prM/E proteins of Japanese encephalitis virus and two hepatitis B virus vaccines.
    NAM JH; BANG HS; CHO HW; CHUNG YH
    Acta Virol; 2007; 51(2):125-30. PubMed ID: 17900219
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses.
    Kreijtz JH; Suezer Y; de Mutsert G; van den Brand JM; van Amerongen G; Schnierle BS; Kuiken T; Fouchier RA; Löwer J; Osterhaus AD; Sutter G; Rimmelzwaan GF
    Vaccine; 2009 Oct; 27(45):6296-9. PubMed ID: 19840663
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Detection of vaccinia virus DNA on the LightCycler by fluorescence melting curve analysis.
    Nitsche A; Steger B; Ellerbrok H; Pauli G
    J Virol Methods; 2005 Jun; 126(1-2):187-95. PubMed ID: 15847936
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Recombinant vaccinia virus expressing Japanese encephalitis virus protein E].
    Cheshenko NV; Petrov VS; Protopopova EV; Netesova NA; Konovalova SN; Belavin PA; Loktev VB; Malygin EG
    Mol Gen Mikrobiol Virusol; 1997; (3):24-7. PubMed ID: 9297107
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An emergent poxvirus from humans and cattle in Rio de Janeiro State: Cantagalo virus may derive from Brazilian smallpox vaccine.
    Damaso CR; Esposito JJ; Condit RC; Moussatché N
    Virology; 2000 Nov; 277(2):439-49. PubMed ID: 11080491
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Protection induced in mice against a lethal orthopox virus by the Lister strain of vaccinia virus and modified vaccinia virus Ankara (MVA).
    Abdalrhman I; Gurt I; Katz E
    Vaccine; 2006 May; 24(19):4152-60. PubMed ID: 16603280
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
    Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
    Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.